Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.
Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.
The new collaboration will be known as Bausch + Lomb Technolas and will continue developing and commercializing surgical laser technology for ophthalmology.
B+L purchased all outstanding shares of Technolas in November 2012 to expand the company's product portfolio into cataract and refractive surgery. The companies have been co-promoting the Victus femtosecond laser, which received marketing approval in Europe in late 2011. Technolas is also developing the Supracor for the treatment of presbyopia.
John Barr, executive president of B+L, commented, "Technolas Perfect Vision’s unique laser platforms will enhance our ability to grow the business and augment our new product pipeline with cutting-edge surgical technology. We are pleased to welcome the Technolas Perfect Vision team to Bausch + Lomb and are committed to a seamless transition as we continue to provide physicians with systems, instruments and intraocular lenses that improve patients’ sight worldwide."
AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill
November 28th 2023At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.
AAO 2023: Marco A. Zarbin, MD, PhD, provides analysis of the YOSEMITE and RHINE clinical trials
November 24th 2023At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials